Evaluation of safety of Brilliant Blue G for inner limiting membrane peeling in patients with vitreomacular diseases

Evaluation of safety of Brilliant Blue G for inner limiting membrane peeling in patients with vitreomacular diseases - Safety of Brilliant Blue G for inner limiting membrane peeling

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031906

Enrollment

1000

Registered

2018-03-27

Start date

2018-03-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

macular hole, epiretinal membrene

Interventions

ILM peeling using BBG

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients requiring peeling of the ILM during vitreous surgery.

Exclusion criteria

Exclusion criteria: Patients who will not agree with this study

Design outcomes

Primary

Measure	Time frame
Post operative complication (e.g. retinal detachment, infection).	—

Countries

Japan

Contacts

Public ContactTomoaki Shiba

School of Medicine, Toho University Ophthalmology

tomoaki-s@med.toho-u.ac.jp03-3761-4151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026